(b)(4).Upon receipt at our post market quality assurance laboratory, a thorough evaluation of the device was performed.During initial investigation, it was reported that the device did not have an elective replacement indicator (eri) timestamp and that end of life (eol) was declared while implanted.Memory analysis found that eol was declared in result of a long charge time.The cause of the long charge time was not determined.Further detailed analysis found no functional irregularities in device operation.All therapy, sensing, and pacing was available at the time of explant.Laboratory analysis confirmed the reported clinical observation.
|